Smithfield Trust’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4K Sell
876
-89
-9% -$670 ﹤0.01% 1006
2025
Q4
$5K Buy
965
+89
+10% +$703 ﹤0.01% 984
2025
Q3
$9K Sell
876
-184
-17% -$1.81K ﹤0.01% 883
2025
Q2
$10K Hold
1,060
﹤0.01% 859
2025
Q1
$16K Sell
1,060
-1
-0.1% -$15 ﹤0.01% 775
2024
Q4
$16K Sell
1,061
-88
-8% -$1.43K ﹤0.01% 792
2024
Q3
$22K Buy
1,149
+79
+7% +$1.64K ﹤0.01% 708
2024
Q2
$21K Sell
1,070
-696
-39% -$13.8K ﹤0.01% 695
2024
Q1
$32K Hold
1,766
﹤0.01% 634
2023
Q4
$26K Sell
1,766
-196
-10% -$2.67K ﹤0.01% 652
2023
Q3
$32K Buy
1,962
+577
+42% +$12K ﹤0.01% 602
2023
Q2
$26K Sell
1,385
-123
-8% -$2.67K ﹤0.01% 657
2023
Q1
$33K Sell
1,508
-299
-17% -$8.03K ﹤0.01% 594
2022
Q4
$47K Sell
1,807
-129
-7% -$3.3K ﹤0.01% 519
2022
Q3
$42K Sell
1,936
-111
-5% -$3.35K ﹤0.01% 535
2022
Q2
$64K Sell
2,047
-36
-2% -$1.26K ﹤0.01% 497
2022
Q1
$66K Sell
2,083
-4
-0.2% -$137 ﹤0.01% 517
2021
Q4
$57K Sell
2,087
-322
-13% -$10.5K ﹤0.01% 545
2021
Q3
$72K Sell
2,409
-90
-4% -$2.88K ﹤0.01% 505
2021
Q2
$76K Buy
+2,499
New +$82.3K 0.01% 487

Other funds holding OGN

Smithfield Trust's OGN Position: Q1 2026 in Review

Smithfield Trust reduced its Organon & Co (OGN) stake by 9.2% in Q1 2026, selling an estimated $670 and leaving 876 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1006.

Smithfield Trust first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $76K in Q2 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Smithfield Trust held 876 shares of Organon & Co worth $4K as of Q1 2026.
  • Smithfield Trust sold 89 Organon & Co shares in Q1 2026, an estimated $670.
  • Organon & Co made up ﹤0.01% of Smithfield Trust's portfolio in Q1 2026, its #1006 holding.
  • Smithfield Trust first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • Smithfield Trust's Organon & Co position peaked at $76K in Q2 2021.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.